Related Experiment Video For FDG PET/CT
Updated: Aug 5, 2026
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Head and Neck Cancers
Archi Agrawal1, Sayak Choudhury1, Manikandan Mv1
1Department of Nuclear Medicine and Molecular Imaging, Homi Bhabha National Institute, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
Abstract:
Imaging is the center-point in the management of head and neck squamous cell carcinomas (HNSCC), as it helps define the extent of the primary tumor, assess regional nodal involvement, detect distant metastases, guide treatment planning, and aid in prognostication and post-treatment surveillance. With advances in molecular imaging, the role of functional imaging techniques has expanded considerably, in particular 18F-fluorodeoxyglucose positron emission computed tomography-computed tomography (18F-FDG PET/CT) has demonstrated added value over conventional imaging and clinical assessment, leading to changes in staging. This article discusses the utility of FDG PET/CT in evaluation of HNSCC.
Related Concept Videos
01:19Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
01:26Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
01:19Muscles that Move the Head
The bilateral sternocleidomastoid, or SCM, and the suprahyoid and infrahyoid muscles are significant head flexors. The SCM muscles originate at the sternum and clavicle and attach to the mastoid process of the temporal bone. The SCM contracts bilaterally to bend the head forward, whereas...
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...